title: Purinergic agonist induction of metallothionein.
abstract: Metallothionein (MT) protein is readily induced in vivo in rat liver by adenosine and adenosine agonists (2-chloroadenosine, 5-(N-ethyl) carboxamido adenosine, and 5-chloro-5-deoxyadenosine). These presumably operate via AMP/adenosine receptors of the P1 (A2) type, which use the cAMP pathway. ATP was ineffective as an inducer for MT. 2-Chloroadenosine was the most effective inducer (7.27-fold at 11 hr). This induction was blockable by the adenosine antagonists, caffeine and theophylline. MT protein induction by 2-chloroadenosine in primary cultured rat hepatocytes was modest (1.55-fold), but this was also blocked by theophylline. MT mRNA induction was assessed using dot blot and Northern gel assays. Large inductions by 2-chloroadenosine (5.1- to 41-fold) were seen, and these were detectable as early as 2 hr in vivo. Two rat hepatoma cell lines (EC3 and 2M) were studied in vitro. Modest inductions of MT mRNA were seen: 2.10-fold for EC3 and 4.12-fold for 2M. Our studies implicate the potential role of the purinergic system in the modulation of transcription of MT genes in rat liver. The sources of adenosine in vivo that might cause induction of MT mRNA and protein are not well defined, but adenosine may be important as a signal in stress response situations involving tissue damage, such as ischemia, hypoxia, and hemorrhagic shock.
authors.affiliation: Department of Biochemistry and Molecular Biology, University of South Dakota School of Medicine, Vermillion 57069.
authors.forename: X
authors.initials: X
authors.lastname: Xiong
authors.forename: S H
authors.initials: SH
authors.lastname: Garrett
authors.forename: K
authors.initials: K
authors.lastname: Arizono
authors.forename: F O
authors.initials: FO
authors.lastname: Brady
mesh_terms: D015762:2-Chloroadenosine / Q000494:pharmacology; D000241:Adenosine / Q000031:analogs & derivatives / Q000494:pharmacology*; D000255:Adenosine Triphosphate / Q000494:pharmacology; D019830:Adenosine-5'-(N-ethylcarboxamide); D000818:Animals; D002110:Caffeine / Q000494:pharmacology; D002478:Cells, Cultured; D017338:Cladribine; D003839:Deoxyadenosines / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D015151:Immunoblotting; D008099:Liver / Q000378:metabolism; D008297:Male; D008668:Metallothionein / Q000378:metabolism*; D012333:RNA, Messenger / Q000096:biosynthesis; D051381:Rats; D011919:Rats, Inbred Strains; D013806:Theophylline / Q000494:pharmacology; D013997:Time Factors; D014158:Transcription, Genetic; D014665:Vasodilator Agents / Q000494:pharmacology
chemical_list: D003839:Deoxyadenosines; D012333:RNA, Messenger; D014665:Vasodilator Agents; C021267:zinc thionein; D015762:2-Chloroadenosine; D019830:Adenosine-5'-(N-ethylcarboxamide); D002110:Caffeine; D017338:Cladribine; C044739:5'-chloro-5'-deoxyadenosine; D000255:Adenosine Triphosphate; D008668:Metallothionein; D013806:Theophylline; D000241:Adenosine